Table 3 Procedural features of the overall population and by groups.
Overall (n = 686) | Cangrelor (n = 198) | Non cangrelor (n = 488) | p | |
|---|---|---|---|---|
Femoral access | 113 (16.5%) | 44 (22.2%) | 69 (14.1%) | 0.010 |
Multivessel CAD | 412 (60.1%) | 102 (51.5%) | 310 (63.5%) | 0.004 |
Treated vessel | ||||
LAD | 343 (50.0%) | 103 (52.0%) | 240 (49.2%) | 0.500 |
CX | 149 (21.7%) | 34 (17.2%) | 115 (23.6%) | 0.066 |
RCA | 205 (29.9%) | 60 (30.3%) | 145 (29.7%) | 0.878 |
LM | 16 (2.3%) | 5 (2.5%) | 11 (2.3%) | 0.831 |
SVG | 10 (1.5%) | 2 (1.0%) | 8 (1.6%) | 0.732 |
Stent number/pt | 1.37 ± 0.75 | 1.47 ± 0.81 | 1.32 ± 0.72 | 0.021 |
Stent number ≥ 2 | 215 (31.3%) | 71 (35.9%) | 144 (29.5%) | 0.104 |
Total stent length | 35.84 ± 20.65 | 38.94 ± 23.60 | 34.50 ± 19.12 | 0.012 |
Multivessel PCI | 83 (12.1%) | 29 (14.6%) | 54 (11.1%) | 0.193 |
Bifurcations | 76 (11.1%) | 27 (13.6%) | 49 (10.0%) | 0.174 |
IIb/IIIa inhibitors infusion | 21 (3.1%) | 3 (1.5%) | 18 (3.7%) | 0.219 |
Drug eluting balloon | 38 (5.5%) | 10 (5.1%) | 28 (5.7%) | 0.721 |
Complex PCI* | 122 (17.8%) | 39 (19.7%) | 83 (17.0%) | 0.404 |
≥ 3 lesions | 13 (1.9%) | 3 (1.5%) | 10 (2.0%) | 0.642 |
≥ 3 vessels | 7 (1.0%) | 4 (2.0%) | 3 (0.6%) | 0.111 |
≥ 3 stents | 50 (7.3%) | 21 (10.6%) | 29 (5.9%) | 0.033 |
≥ 60 mm total stent length | 88 (12.8%) | 34 (17.2%) | 54 (11.1%) | 0.030 |
2-stents technique bifurcations | 31 (4.5%) | 8 (4.0%) | 23 (4.7%) | 0.701 |
Chronic total occlusion lesions | 4 (0.6%) | 0 (0%) | 4 (0.8%) | 0.583 |
Transferred for surgical revascularization | 28 (4.1%) | 8 (4.0%) | 20 (4.1%) | 0.972 |
Slow/no reflow | 24 (3.5%) | 6 (3.0%) | 18 (3.7%) | 0.671 |
